<DOC>
	<DOCNO>NCT01113307</DOCNO>
	<brief_summary>The primary objective study define procedure use CureXcellTM community Clalit Health Services . Secondary objective evaluate blinding method subgroup patient , use future study name : multinational , multi-center , randomize , double blind , placebo control study evaluation tolerability , safety efficacy CureXcell™ therapy plus adequate ulcer treatment , diabetic patient ulcer low extremity . Adults chronic ulcer ; pressure ulcer , venous ulcer , diabetic foot ulcer post operative ulcer recruit study . Patients recruit study treat require medical condition . As require , culture take , IV PO antibiotic give debridement carry . Patients referred catheterization , revascularization , amputation require decision affect way study . CureXcellTM use adjunct treatment good ulcer care ( GUC ) .</brief_summary>
	<brief_title>The Use CureXcellTM Community Setting Treatment Hard Heal Wounds</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>1 . Patients 18 90 year age one ulcer show sign normal healing ( accord physician experience wound therapy ) 3 week 2 . The patient suffers diabetic ulcer , decubitus ulcer , venous insufficiency ulcer post operative wound . 3 . In patient suspected malnutrition albumin &gt; 2.5 g/dL blood test perform within last three week . 4 . Patients adequate blood perfusion : palpate distal pulse TP DP palpable , arterial pressure rest ABI &gt; 0.6 . 5 . Patients without edema +2 ( patient 's edema must control medical and/or bandage lympha press ) . 6 . Use elastic bandaging wound due venous insufficiency ( involvement arterial problem ) . 7 . Wound condition immediately jeopardize extremity . 8 . The patient 's life risk ( reason ) . 9 . The Patient life expectancy least one year . 10 . Women childbearing potential must willing use reliable method birth control . 11 . Willing able sign inform consent form attend follow accord treat staff instruction complete wound closure . Inclusion criterion 'treatment blind guess test ' : 1 . A patient suffering diabetes chronic ulcer low extremity ( ankle ) CureXcell™ naive . 2 . Signing appendix consent form 'treatment blind guess test ' . 1 . More one wound ; 2 . Inadequately treated recurrent pressure component wound . If require , ulcer treat preliminary treatment local pressure component ( shoe even cast wheel chair treatment period ) 3 . Neoplastic ulcer 4 . A patient active malignant disease last five year , except patient suffer adequately treat Basal Cell Carcinoma present wind area . 5 . Sepsis 6 . Confirmed osteomyelitis 7 . Patients suffer significant immunosuppression . 8 . INR &gt; 3 patient receive anticoagulation drug , blood test perform within two week prior first injection 9 . A response previous blood infusion ( case administer ) 10 . Patient receive unique blood component ( radiate , wash etc . ) 11 . Pregnant patient 12 . Wounds year 13 . A fistula/cavity anatomical shape enable direct injection wind 14 . A patient participate another clinical trial , participate another clinical trial within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Chronic ulcer</keyword>
	<keyword>pressure ulcer</keyword>
	<keyword>venous ulcer</keyword>
	<keyword>diabetic foot ulcer</keyword>
	<keyword>post operative ulcer</keyword>
	<keyword>hard heal ulcer</keyword>
</DOC>